Patent Assignment
Reel/Frame 034566/0976
Certificate of Conversion
Recorded: 2014-12-09
Pages: 5
Assignor
AVENTISUB INC.
Executed: 2014-06-16
Assignee
AVENTISUB LLC
3711 KENNETT PIKE, SUITE 200, GREENVILLE, DELAWARE, 19807
Covered Properties
(70)
Protein Tyrosine Kinase Aryl and Heteroaryl Quinazoline Compounds Having Selective Inhibition of Her-2 Autophosphorylation Properties
Patent:
5,721,237 →
Application:
08/469,147 →
Pluripotential Quiescent Stem Cell Population
Patent:
5,807,686 →
Application:
08/482,318 →
Aqueous-Based Pharmaceutical Composition
Patent:
5,976,573 →
Application:
08/678,465 →
Antithrombotic Azacycloalkylalkanoyl Peptides and Pseudopeptides
Patent:
5,780,590 →
Application:
08/700,950 →
Synthesis of Terfenadine and Derivatives
Patent:
5,925,761 →
Application:
08/803,895 →
Substituted (Aryl, Heteroaryl, Arylmethyl or Heteroarylmethyl) Hydroxamic Acid Compounds
Patent:
6,057,369 →
Application:
08/928,943 →
Transgenic Rabbit That Expresses a Functional Human Lipoprotein (A)
Patent:
6,512,161 →
Application:
09/227,701 →
Method for Controlling the Extension of an Oligonucleotide
Patent:
6,200,757 →
Application:
09/233,413 →
Piperididinyl and N-Amidinopiperidinyl Derivatives
Patent:
6,277,865 →
Application:
09/273,618 →
Aqueous-Based Pharmaceutical Composition
Patent:
6,143,329 →
Application:
09/315,454 →
Synthesis of Terfenadine and Derivatives
Patent:
6,147,217 →
Application:
09/316,104 →
Elastomer Treatment Process to Decrease Peroxide Levels
Patent:
6,248,841 →
Application:
09/355,693 →
Substituted Beta-Thiocarboxylic Acids
Patent:
6,306,873 →
Application:
09/357,734 →
Methods for Preparing N-[(Aliphatic or Aromatic)Carbonyl)]-2-Aminoacetamide Compounds and for Cyclizing Such Compounds
Patent:
6,492,553 →
Application:
09/368,213 →
Luciferase Reporter Bioassay of Parathyroid Hormone Compounds
Patent:
6,720,153 →
Application:
09/387,176 →
Electrochemiluminescence Helicase Assay
Akt Nucleic Acids, Polypeptides, and Uses Thereof
Aqueous-based pharmaceutical composition
Patent:
6,375,984 →
Application:
09/561,371 →
Nuclear Factor Kappab Inducing Factor
Chemical Compounds
Dissolution Test Sample Holder
Patent:
6,929,782 →
Application:
09/890,484 →
Acyl and Sulfonyl Derivatives of 6,9-Disubstituted 2-(Trans-1,4-Diaminocyclohexyl)-Purines and Their Use as Antiproliferative Agents
Method of Treating of Demyelinating Diseases or Conditions
Use of (Z) -2-Cyano-3-Hydroxy-but-2-Enoic Acid-(4' -Trifluoromethylphenyl)-Amide for Treating Multiple Sclerosis
Aqueous-Based Pharmaceutical Composition
Benzimidazoles
Transposon Mediated Multiplex Sequencing
Human Analogs of Murine Deubiquitinating Proteases
Human Deubiquitinating Protease Gene on Chromosome 7 and Its Murine Ortholog
Novel G Protein-Coupled Receptor, Gave 10
Pyrazoloisoquinoline Derivative as Kinase Inhibitors for the Treatment of Various Disorders
1-Aroyl-Piperidinyl Benzamidines
Acyl and Sulfonyl Derivatives of 6,9-Disubstituted 2-(Trans-1,4-Diaminocyclohexyl)-Purines and Their Use as Antiproliferative Agents
Prostaglandin Receptor Protein and Methods of Use Thereof
Method for Reducing Cardiovascular Morbidity and Mortality in Prediabetic Patients and Patients with Type 2 Diabetes
Application of 2-Cyano-10- (2-Methyl-3- (Methylamino)- Propyl) Phenothiazine or a Pharmaceutically Acceptable Salt as Medicament
Novel Compounds and Compositions as Cathepsin Inhibitors
Coumarins as Inos Inhibitors
Substituted 1H-Pyrrolo[3,2-B, 3,2-C, and 2,3-C]Pyridine-2-Carboxamides and Related Analogs as Inhibitors of Casein Kinase Lepsilon
Benzimidazoles
Oxydecahydronaphthalene Modulators of HM74
Human AKT3 Nucleic Acid and Uses Thereof
Method of Treating of Demyelinating Diseases or Conditions
Method of Treating Demyelinating Diseases or Conditions
Nuclear Factor Kappab Inducing Factor
Substituted Pyridones as Inhibitors of Poly(Adp-Ribose) Polymerase (Parp)
Substituted Propane Phosphinic Acid Derivatives
N-Sulfonylpipecolic Acid Derivative Fkbp Binding Composition and Pharmaceutical Use Thereof
Prostaglandin Receptor Protein
Substituted Thienopyrrole Carboxylic Acid Amides, Pyrrolothiazole Carboxylic Acid Amides, and Related Analogs as Inhibitors of Casein Kinase I
3-Substituted-5- and 6-Aminoalkyl Indole-2-Carboxylic Acid Amides and Related Analogs as Inhibitors of Casein Kinase I
3-Arylthioindole-2-Carboxamide Derivatives and Analogs Thereof as Inhibitors of Casein Kinase I
Method for Measuring Resistance or Sensitivity to Docetaxel
Application:
11/721,103 →
Publication:
US 2009/0226894
2,6-Substituted-4-Monosubstitutedamino-Pyrimidine as Prostaglandin D2 Receptor Antagonists
2,6-Substituted-4-Monosubstitutedamino-Pyrimidine as Prostaglandin D2 Receptor Antagonists
Substituted Propane Phosphinic Acid Esters
Substituted Bis Aryl and Heteroaryl Compounds as Selective 5HT2A Antagonists
Combination of a Hypnotic Agent and Substituted Bis Aryl and Heteroaryl Compound and Therapeutic Application Thereof
Pyrimidine Amide Compounds as Pgds Inhibitors
SUBSTITUTED 1H-PYRROLO[2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE le
Substituted Thienopyrrole Carboxylic Acid Amides, Pyrrolothiazole Carboxylic Acid Amides, and Related Analogs as Inhibitors of Casein Kinase I
Method for Reducing Cardiovascular Morbidity and Mortality in Prediabetic Patients and Patients with Type 2 Diabetes
3-Substituted-5- and 6-Aminoalkyl Indole-2-Carboxylic Acid Amides and Related Analogs as Inhibitors of Casein Kinase I
Nucleic Acid Molecules Encoding Prostaglandin Receptor Proteins
Akt Nucleic Acids, Polypeptides, and Uses Thereof
Aqueous-Based Pharmaceutical Composition
NUCLEAR FACTOR kappaB INDUCING FACTOR
Nuclear Factor Kappab Inducing Factor
Substituted Propane Phosphinic Acid Derivatives
Method for Reducing Cardiovascular Morbidity and Mortality in Prediaetic Patients and Patients with Type 2 Diabetes
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Dec 9, 2014
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 034565/0935 →
Change of Name
Dec 9, 2014
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 034566/0212 →
Merger
Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →